FDA Authorizes Covid-Flu Combo Test for Home-Collected Samples

The FDA authorized the first diagnostic test for at home collection of patient samples to detect both Covid-19 and influenza A and B.

• The FDA authorized Quest Diagnostics RC Covid-19 + Flu RT-PCR Test for prescription use with the Quest Diagnostics Self-Collection Kit for Covid-19 + Flu by individuals who are suspected of respiratory viral infection consistent with Covid-19 when home collection is determined to be appropriate by an individual’s healthcare provider

To view the source of this information click here

To contact the reporter on this story:
Hari Govind in San Francisco at hgovind@bloomberg.net

To contact the editor responsible ...